Takafumi Takai

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2011-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takafumi Takai. Retrieved from https://idiyas.com/inventor/takafumi-takai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 33.3

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 16(Granted Patents)

Location History:

Osaka, JP (2011 - 2014)
Kanagawa, JP (2013 - 2014)

Company Filing History:

12 out of 1,228

Takeda Pharmaceutical Company Limited

patents

Years Active: 2011-2014

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8901309 - Fused triazoles for the treatment or prophylaxis of mild cognitive impairment (2014-12-02),

2. 8901141 - Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them (2014-12-02),

3. 8895591 - Tricyclic compound and pharmaceutical use thereof (2014-11-25),

4. 8822699 - Heterocyclic compound and use thereof (2014-09-02),

5. 8785460 - Tricyclic compounds and use thereof (2014-07-22),

6. 8552037 - Tricyclic compound and pharmaceutical use thereof (2013-10-08),

7. 8349879 - Tricyclic compound and pharmaceutical use thereof (2013-01-08),

8. 8273761 - Tricyclic compound and medical use thereof (2012-09-25),

9. 8247429 - Tricyclic compound and pharmaceutical use thereof (2012-08-21),

10. 8236837 - Tricyclic compound and pharmaceutical use thereof (2012-08-07),

11. 8110585 - Bicyclic compound and pharmaceutical use thereof (2012-02-07),

12. 8030337 - Tricyclic compound and pharmaceutical use thereof (2011-10-04),

Title: The Innovations of Takafumi Takai

Introduction

Takafumi Takai is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 12 patents to his name, Takai's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Takai has developed tricyclic compounds that exhibit corticotropin-releasing factor antagonistic activity. This invention includes a compound represented by a specific formula, which has potential applications in treating various conditions. Another notable patent involves fused triazoles aimed at the treatment or prophylaxis of mild cognitive impairment. This invention provides a heterocycle derivative that demonstrates superior amyloid β production inhibitory activity and/or superior γ-secretase modulation activity.

Career Highlights

Takafumi Takai is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda has allowed him to focus on innovative solutions that address critical health issues. His research and inventions have contributed to advancements in drug development and therapeutic strategies.

Collaborations

Throughout his career, Takai has collaborated with notable colleagues, including Tatsuki Koike and Yasutaka Hoashi. These collaborations have fostered a productive environment for innovation and have led to the successful development of various pharmaceutical compounds.

Conclusion

Takafumi Takai's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to influence the development of new therapeutic options for patients worldwide.

Profile summary based on public USPTO records.